TY - JOUR
T1 - The UK DNA banking network: A "fair access'' biobank
AU - Yuille, Martin
AU - Dixon, Katherine
AU - Platt, Andrew
AU - Pullum, Simon
AU - Lewis, David
AU - Hall, Alistair
AU - Ollier, William
PY - 2010/8
Y1 - 2010/8
N2 - The UK DNA Banking Network (UDBN) is a secondary biobank: it aggregates and manages resources (samples and data) originated by others. The network comprises, on the one hand, investigator groups led by clinicians each with a distinct disease specialism and, on the other hand, a research infrastructure to manage samples and data. The infrastructure addresses the problem of providing secure quality-assured accrual, storage, replenishment and distribution capacities for samples and of facilitating access to DNA aliquots and data for new peerreviewed studies in genetic epidemiology. 'Fair access' principles and practices have been pragmatically developed that, unlike open access policies in this area, are not cumbersome but, rather, are fit for the purpose of expediting new study designs and their implementation. UDBN has so far distributed > 60,000 samples for major genotyping studies yielding >10 billion genotypes. It provides a working model that can inform progress in biobanking nationally, across Europe and internationally. © Springer Science+Business Media B.V. 2009.
AB - The UK DNA Banking Network (UDBN) is a secondary biobank: it aggregates and manages resources (samples and data) originated by others. The network comprises, on the one hand, investigator groups led by clinicians each with a distinct disease specialism and, on the other hand, a research infrastructure to manage samples and data. The infrastructure addresses the problem of providing secure quality-assured accrual, storage, replenishment and distribution capacities for samples and of facilitating access to DNA aliquots and data for new peerreviewed studies in genetic epidemiology. 'Fair access' principles and practices have been pragmatically developed that, unlike open access policies in this area, are not cumbersome but, rather, are fit for the purpose of expediting new study designs and their implementation. UDBN has so far distributed > 60,000 samples for major genotyping studies yielding >10 billion genotypes. It provides a working model that can inform progress in biobanking nationally, across Europe and internationally. © Springer Science+Business Media B.V. 2009.
KW - Biobanking
KW - Genetic epidemiology
KW - Research infrastructure
UR - https://www.scopus.com/pages/publications/77956835821
U2 - 10.1007/s10561-009-9150-3
DO - 10.1007/s10561-009-9150-3
M3 - Article
SN - 1389-9333
VL - 11
SP - 241
EP - 251
JO - Cell and Tissue Banking
JF - Cell and Tissue Banking
IS - 3
ER -